For: | Leitner GC, Vogelsang H. Pharmacological- and non-pharmacological therapeutic approaches in inflammatory bowel disease in adults. World J Gastrointest Pharmacol Ther 2016; 7(1): 5-20 [PMID: 26855808 DOI: 10.4292/wjgpt.v7.i1.5] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v7/i1/5.htm |
Number | Citing Articles |
1 |
Sundus Bhatti, Imad Jaafar, Hamza Hassan, Hadi Atassi, Abigail Stocker, Michael Hughes, Christina Pinkston, Gerald Dryden, Thomas Abell. Effects of Gastric Neuromodulation on Crohn’s Disease in Patients With Coexisting Symptoms of Gastroparesis. Neuromodulation: Technology at the Neural Interface 2020; 23(8): 1196 doi: 10.1111/ner.13118
|
2 |
Sihem Ait‐Oudhia, Yi Ting (Kayla) Lien, Sumit Basu, Lawrence Lesko, Stephan Schmidt. Quantitative Pharmacology and Individualized Therapy Strategies in Development of Therapeutic Proteins for Immune‐Mediated Inflammatory Diseases. 2019; : 209 doi: 10.1002/9781119289234.ch10
|
3 |
Mariana Ferreira-Duarte, Tiago Rodrigues-Pinto, Teresa Sousa, Miguel A. Faria, Maria Sofia Rocha, Daniela Menezes-Pinto, Marisa Esteves-Monteiro, Fernando Magro, Patrícia Dias-Pereira, Margarida Duarte-Araújo, Manuela Morato. Interaction between the Renin–Angiotensin System and Enteric Neurotransmission Contributes to Colonic Dysmotility in the TNBS-Induced Model of Colitis. International Journal of Molecular Sciences 2021; 22(9): 4836 doi: 10.3390/ijms22094836
|
4 |
Christophe Passot, Denis Mulleman, Theodora Bejan-Angoulvant, Alexandre Aubourg, Stephanie Willot, Thierry Lecomte, Laurence Picon, Philippe Goupille, Gilles Paintaud, David Ternant. The underlying inflammatory chronic disease influences infliximab pharmacokinetics. mAbs 2016; 8(7): 1407 doi: 10.1080/19420862.2016.1216741
|
5 |
Taraneh Mousavi, Shokoufeh Hassani, Maryam Baeeri, Mahban Rahimifard, Faezeh Vakhshiteh, Mahdi Gholami, Elmira Ghafour-Broujerdi, Mohammad Abdollahi. Comparison of the safety and efficacy of fingolimod and tofacitinib in the zebrafish model of colitis. Food and Chemical Toxicology 2022; 170: 113509 doi: 10.1016/j.fct.2022.113509
|
6 |
Emre Gerçeker, Hakan Yüceyar, Elmas Kasap, Ufuk Demirci, Burcu Ceren Ekti, İsmet Aydoğdu, Mine Miskioğlu. Treatment of inflammatory bowel disease by leukocytapheresis. Transfusion and Apheresis Science 2017; 56(3): 421 doi: 10.1016/j.transci.2017.03.016
|
7 |
Daniel Ferri, Pablo Gaviña, Margarita Parra, Ana M. Costero, Jamal El Haskouri, Pedro Amorós, Virginia Merino, Adrián H. Teruel, Félix Sancenón, Ramón Martínez-Máñez. Mesoporous silica microparticles gated with a bulky azo derivative for the controlled release of dyes/drugs in colon. Royal Society Open Science 2018; 5(8): 180873 doi: 10.1098/rsos.180873
|
8 |
Mohamed Salla, Jimmy Guo, Harshad Joshi, Marilyn Gordon, Hitesh Dooky, Justine Lai, Samantha Capicio, Heather Armstrong, Rosica Valcheva, Jason R. B. Dyck, Aducio Thiesen, Eytan Wine, Levinus A. Dieleman, Shairaz Baksh. Novel Biomarkers for Inflammatory Bowel Disease and Colorectal Cancer: An Interplay between Metabolic Dysregulation and Excessive Inflammation. International Journal of Molecular Sciences 2023; 24(6): 5967 doi: 10.3390/ijms24065967
|
9 |
Jisu Kim, Suji Baek, Nan Hee Choi, Seung-Hae Kwon, So Hui Lee, Kang Pa Lee. Protective Effect of Korean Hedyotis diffusa Extract Against Dextran Sulfate Sodium-induced Colitis in Mice. International Journal of Pharmacology 2020; 16(4): 291 doi: 10.3923/ijp.2020.291.297
|
10 |
Hyun Kyeong Yoo, Han Geul Byun, Flavio Caprioli, Mathurin Fumery, Laurent Peyrin-Biroulet, Subramanian Sreedhar, James Potter, Minyoung Jang. Budget impact analysis of the subcutaneous infliximab (CT-P13 SC) for treating inflammatory bowel disease in the Big-5 European (E5) countries. BMC Health Services Research 2022; 22(1) doi: 10.1186/s12913-022-08683-y
|
11 |
Ali Sen, Meral Yuksel, Gizem Bulut, Leyla Bitis, Feriha Ercan, Nagehan Ozyilmaz-Yay, Ozben Akbulut, Hamit Cobanoğlu, Sevil Ozkan, Goksel Sener. Therapeutic Potential ofMyrtus communisSubsp.communisExtract Against Acetic ACID-Induced Colonic Inflammation in Rats. Journal of Food Biochemistry 2017; 41(1): e12297 doi: 10.1111/jfbc.12297
|
12 |
Jie Ren, Dong Yan, Yichun Wang, Jiaojiao Zhang, Min Li, Wancheng Xiong, Xueqian Jing, Puze Li, Weidong Zhao, Xiwen Xiong, Minna Wu, Genshen Zhong. Inhibitor of Differentiation-2 Protein Ameliorates DSS-Induced Ulcerative Colitis by Inhibiting NF-κB Activation in Neutrophils. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.760999
|
13 |
M.M. Chulkina, A.V. Pichugin, R.I. Ataullakhanov. Pharmaceutical grade synthetic peptide Thr-Glu-Lys-Lys-Arg-Arg-Glu-Thr-Val-Glu-Arg-Glu-Lys-Glu ameliorates DSS-induced murine colitis by reducing the number and pro-inflammatory activity of colon tissue-infiltrating Ly6G+ granulocytes and Ly6C+ monocytes. Peptides 2020; 132: 170364 doi: 10.1016/j.peptides.2020.170364
|
14 |
Semih KALYON, Yasemin GÖKDEN, Fırat OYMAN. A new biological marker in inflammatory bowel disease: Pentraxin 3. Journal of Surgery and Medicine 2020; 4(10): 875 doi: 10.28982/josam.791156
|
15 |
Kendra J. Kamp, Kelly Brittain. Factors that Influence Treatment and Non-treatment Decision Making Among Individuals with Inflammatory Bowel Disease: An Integrative Review. The Patient - Patient-Centered Outcomes Research 2018; 11(3): 271 doi: 10.1007/s40271-017-0294-0
|
16 |
Allison L. Goetsch, Dana Kimelman, Teresa K. Woodruff. Fertility Preservation and Restoration for Patients with Complex Medical Conditions. 2017; : 249 doi: 10.1007/978-3-319-52316-3_15
|
17 |
Jayshree Mishra, Madyson Stubbs, Longxiang Kuang, Nitza Vara, Priyam Kumar, Narendra Kumar, Veedamali S. Subramanian. Inflammatory Bowel Disease Therapeutics: A Focus on Probiotic Engineering. Mediators of Inflammation 2022; 2022: 1 doi: 10.1155/2022/9621668
|
18 |
Cintia M. S. Cereda, Giovana R. Tofoli. Biotechnology Applied to Inflammatory Diseases. Interdisciplinary Biotechnological Advances 2023; : 287 doi: 10.1007/978-981-19-8342-9_13
|
19 |
Shuzan Ali Mohammed, Azza Elbaramawy, Somia Hassan Abd‐Allah, Adel Elkholy, Nashwa Ibrahim Elsayed, Samia Hussein. Therapeutic potentials of mesenchymal stem cells in the treatment of inflammatory bowel disease in rats. Journal of Biochemical and Molecular Toxicology 2024; 38(1) doi: 10.1002/jbt.23532
|
20 |
Elżbieta Kamysz, Maciej Sałaga, Małgorzata Sobocińska, Artur Giełdoń, Jakub Fichna. Anti-Inflammatory Effect of Novel Analogs of Natural Enkephalinase Inhibitors in a Mouse Model of Experimental Colitis. Future Medicinal Chemistry 2016; 8(18): 2231 doi: 10.4155/fmc-2016-0156
|
21 |
J.L. Cabriada, I. Rodríguez-Lago. Granulocitoaféresis en 2017. Puesta al día. Enfermedad Inflamatoria Intestinal al Día 2017; 16(2): 62 doi: 10.1016/j.eii.2016.12.001
|
22 |
Nina Worel, Behrouz Mansouri Taleghani, Erwin Strasser. Recommendations for Therapeutic Apheresis by the Section “Preparative and Therapeutic Hemapheresis” of the German Society for Transfusion Medicine and Immunohematology. Transfusion Medicine and Hemotherapy 2019; 46(6): 394 doi: 10.1159/000503937
|
23 |
Matteo Martinato, Elena Boffo, Greta Lorenzon, Eleonora Monaco, Clara Iervolino, Rosanna Irene Comoretto, Edoardo Vincenzo Savarino, Dario Gregori. Nursing Interventions Targeting Fatigue in Inflammatory Bowel Disease: A Systematic Review. Gastrointestinal Disorders 2024; 6(3): 706 doi: 10.3390/gidisord6030047
|
24 |
Taraneh Mousavi, Shekoufeh Nikfar, Mohammad Abdollahi. Comprehensive study on the administrative, economic, regional, and regulatory prospects of complementary and alternative medicine (CAM) in inflammatory bowel disease (IBD). Expert Review of Clinical Pharmacology 2021; 14(7): 865 doi: 10.1080/17512433.2021.1925108
|
25 |
Yi Xu, David J. Baylink, Huynh Cao, Jeffrey Xiao, Maisa I. Abdalla, Samiksha Wasnik, Xiaolei Tang. Inflammation- and Gut-Homing Macrophages, Engineered to De Novo Overexpress Active Vitamin D, Promoted the Regenerative Function of Intestinal Stem Cells. International Journal of Molecular Sciences 2021; 22(17): 9516 doi: 10.3390/ijms22179516
|
26 |
Kazuhiko Ono, Satoshi Nimura, Yuko Hideshima, Kazuki Nabeshima, Manabu Nakashima. Orally administered sodium 4‑phenylbutyrate suppresses the development of dextran sulfate sodium‑induced colitis in mice. Experimental and Therapeutic Medicine 2017; doi: 10.3892/etm.2017.5251
|
27 |
Xiaoyi Liu, Shuai Chen, Huijuan Liu, Jiao Xie, K. M. Faridul Hasan, Qibing Zeng, Shaofeng Wei, Peng Luo. Structural properties and anti-inflammatory activity of purified polysaccharides from Hen-of-the-woods mushrooms (Grifola frondosa). Frontiers in Nutrition 2023; 10 doi: 10.3389/fnut.2023.1078868
|
28 |
Faisal Inayat, Waqas Ullah, Qulsoom Hussain, Khurram Shafique. Crohn’s disease presenting as gastric outlet obstruction: a therapeutic challenge?. BMJ Case Reports 2017; : bcr-2016-218181 doi: 10.1136/bcr-2016-218181
|
29 |
Carolina Martins Lázaro, Carolina C. de Oliveira, Alessandra Gambero, Thalita Rocha, Cintia Maria Saia Cereda, Daniele Ribeiro de Araújo, Giovana Radomille Tofoli. Evaluation of Budesonide–Hydroxypropyl-β-Cyclodextrin Inclusion Complex in Thermoreversible Gels for Ulcerative Colitis. Digestive Diseases and Sciences 2020; 65(11): 3297 doi: 10.1007/s10620-020-06075-y
|
30 |
Karen Dubois-Camacho, Payton A Ottum, Daniel Franco-Muñoz, Marjorie De la Fuente, Alejandro Torres-Riquelme, David Díaz-Jiménez, Mauricio Olivares-Morales, Gonzalo Astudillo, Rodrigo Quera, Marcela A Hermoso. Glucocorticosteroid therapy in inflammatory bowel diseases: From clinical practice to molecular biology. World Journal of Gastroenterology 2017; 23(36): 6628-6638 doi: 10.3748/wjg.v23.i36.6628
|
31 |
J. Winny Yun, Alireza Minagar, J. Steven Alexander. Inflammatory Disorders of the Nervous System. 2017; : 1 doi: 10.1007/978-3-319-51220-4_1
|
32 |
Daniel Muthas, Anna Reznichenko, Clare A. Balendran, Gerhard Böttcher, Ib Groth Clausen, Carina Kärrman Mårdh, Tomas Ottosson, Mohib Uddin, Thomas T. MacDonald, Silvio Danese, Mark Berner Hansen. Neutrophils in ulcerative colitis: a review of selected biomarkers and their potential therapeutic implications. Scandinavian Journal of Gastroenterology 2017; 52(2): 125 doi: 10.1080/00365521.2016.1235224
|
33 |
Claire J. Han, Margaret M. Heitkemper. Handbook of Sleep Disorders in Medical Conditions. 2019; : 371 doi: 10.1016/B978-0-12-813014-8.00017-2
|
34 |
K. Balendran, S. Udumalagala, N. M. M. Nawaraththne. Pyloric stenosis as a manifestation of isolated gastric Crohn’s disease responding to intralesional steroid injection and balloon dilation: a case report. Journal of Medical Case Reports 2019; 13(1) doi: 10.1186/s13256-019-2272-8
|
35 |
González-Ramírez Adriana Estrella, González-Trujano María Eva, Hernandez-Leon Alberto, Valle-Dorado María Guadalupe, Carballo-Villalobos Azucena, Orozco-Suárez Sandra, Alvarado-Vásquez Noé, López-Muñoz Francisco Javier. Limonene from Agastache mexicana essential oil produces antinociceptive effects, gastrointestinal protection and improves experimental ulcerative colitis. Journal of Ethnopharmacology 2021; 280: 114462 doi: 10.1016/j.jep.2021.114462
|
36 |
Mahmoud Mosli, Sultan Alfaer, Turki Almalaki, Abdulrahman Albeshry, Saja Aljehani, Bashaer Alshmrani, Zaineb Habib, Hani Jawa, Yousif Qari. Baseline risk assessment of patients with ulcerative colitis: does initial treatment selection influence outcomes?. European Journal of Gastroenterology & Hepatology 2019; 31(1): 80 doi: 10.1097/MEG.0000000000001249
|
37 |
Farah Yasmin, Hala Najeeb, Unaiza Naeem, Abdul Moeed, Thoyaja Koritala, Salim Surani. Apheresis: A cell-based therapeutic tool for the inflammatory bowel disease. World Journal of Clinical Cases 2022; 10(21): 7195-7208 doi: 10.12998/wjcc.v10.i21.7195
|